萊佛士重慶醫院被視為一個大膽之舉，透露出萊佛士急於向國外拓展市場，挽救業績下滑的窘境。
由於中國的創業成本，新加坡最大的私人醫療集團——萊佛士醫療集團（RMG）2019年第一季度利潤大幅下滑。重慶萊佛士醫院被視為在中國醫療市場大膽創業的開始，為萊佛士提供無限擴展服務的機會。
重慶萊佛士醫院。
在可比較的基礎上，若不計中國新醫院的成本，該集團的利潤將增長2.1％。在今年的展望中，萊佛士方面表示，預計將在2019年增加收入並保持盈利，「 儘管重慶萊佛士醫院預計會出現發展期虧損 」。
A bold new venture into the Chinese healthcare market
First quarter profits have slumped at Raffles Medical Group (RMG), the largest private medical group practice in Singapore, thanks to startup costs in China. Raffles Hospital Chongqing is seen as the beginning of a bold new venture into the Chinese healthcare market for RMG providing unlimited opportunities to expand its services.
On a comparable basis, excluding the costs of the new hospital, the group’s profits would have grown by 2.1%. In its outlook for the year, the RMG said that it expected to grow its revenue and remain profitable in 2019, "notwithstanding the expected gestation loss for Raffles Hospital Chongqing".
